🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Invasive Ductal Breast Carcinoma

Endoscopic Nipple-Sparing Mastectomy Through a Single Axillary Incision in Breast Cancer NCT07507890NA1 site📍 Candiolo Fondazione del Piemonte per l'Oncologia · Tests: Endoscopic Nipple-Sparing Mastectomy (E-NSM) Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery NCT04169542n/a4 sites📍 Conroe📍 Houston📍 League City M.D. Anderson Cancer Center · Tests: Questionnaire Administration Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer NCT02918474NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Decision Aid, Questionnaire Administration Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT) NCT04985032n/a2 sites📍 Stuart📍 Tampa RPCR, Inc. · Tests: stereotactic body radiation therapy Biomarkers to Detect Endocrine Therapy Resistance NCT06067503Phase 21 site📍 Madison University of Wisconsin, Madison · Tests: 18F-fluorofuranylnorprogesterone, Liquid Biopsy, Positron Emission Tomography/Computed Tomography Immun Checkpoint Washout in Patients With Invasive Ductal Breast Cancer NCT07003009NA1 site📍 Istanbul Istanbul Training and Research Hospital · Tests: Malign Lymph Node Washout, Benign Lymph Node Washout Single-Fraction Very Accelerated Partial Breast Irradiation (sfVAPBI) NCT07067437NA23 sites📍 Lyon📍 Nancy📍 Nice National Institute of Oncology, Hungary · Tests: single-fraction very accelerated partial breast irradiation Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer NCT04959474NA1 site📍 Philadelphia Thomas Jefferson University · Tests: Best Practice, Stereotactic Body Radiation Therapy, Resection, Sentinel Lymph Node Biopsy, Dietary Intervention Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer NCT06984250n/a2 sites📍 Taipei📍 Taipei National Taiwan University Hospital · Tests: Hypofractionated Radiation Therapy A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer NCT07483307Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Neoadjuvant endocrine therapy A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue NCT05837767NA7 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Palliative radiotherapy Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women NCT03201861Phase 31 site📍 Shanghai RenJi Hospital · Tests: Paclitaxel, Cisplatin, EC to docetaxel or paclitaxel Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy NCT07711847NA1 site📍 New York HeroSupport SA · Tests: VENUS SHELL™ immobilization device [68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC) NCT07020806Phase 11 site📍 Sacramento University of California, Davis · Tests: [68Ga]Ga DOTA-5G The PREDICT Registry: NCT03448926n/a30 sites📍 Scottsdale📍 La Jolla📍 San Mateo PreludeDx · Tests: Treatment recommendation surveys, 7-gene biosignature Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers NCT05919108Phase 25 sites📍 Atlanta📍 Pittsburgh📍 Nashville Vanderbilt-Ingram Cancer Center · Tests: Endocrine Therapy, Biopsy of breast, Neratinib, Biospecimen Collection, Mammogram 5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer NCT06961955Phase 21 site📍 Salt Lake City University of Utah · Tests: Radiation Therapy Radiation After No Axillary Nodal Sampling NCT07723209NA1 site📍 New York NYU Langone Health · Tests: Partial Breast Irradiation (PBI) Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors NCT05269381Phase 1, Phase 21 site📍 Jacksonville Mayo Clinic · Tests: Cyclophosphamide, Neoantigen Peptide Vaccine, Pembrolizumab, Sargramostim, Biospecimen Collection Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma NCT03909282NA1 site📍 Stanford Stanford University · Tests: Lumpectomy, Partial breast irradiation prior to surgery Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions NCT06903468NA1 site📍 Gainesville University of Florida · Tests: Novel cavity marking technique Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer NCT04084730Phase 29 sites📍 Norwalk📍 Miami📍 Basking Ridge Memorial Sloan Kettering Cancer Center · Tests: Accelerated Partial Breast Irradiation Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer NCT06666439n/a1 site📍 Pittsburgh Julia Foldi · Tests: circulating tumor DNA (ctDNA) Negative/Low Hormone Receptor And/or HER2 POsitive Lobular Invasive Breast Carcinoma - A Real-World International Cohort Study NCT07613151n/a1 site📍 Padova Istituto Oncologico Veneto IRCCS · Tests: Upfront Breast Surgery, Adjuvant Radiotherapy, Endocrine Therapy, Chemotherapy A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors NCT05706129Phase 1, Phase 210 sites📍 Melbourne📍 Sydney📍 Clermont-Ferrand Lumara Bio Oncologics GmbH · Tests: [68Ga]Ga-DPI-4452, [177Lu]Lu-DPI-4452 Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer NCT04790305Phase 434 sites📍 Hefei📍 Hefei📍 Beijing Fudan University · Tests: Huaier Granule Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer NCT06677944Phase 21 site📍 Seoul Yonsei University · Tests: Preoperative PBI [68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications NCT07702292Phase 26 sites📍 Bergamo📍 Monza📍 Roma Blue Earth Diagnostics · Tests: [68Ga]BED003 Multimodal Imaging With FAPI-PET/MRI in Breast Carcinoma-In-Situ for Detection of Occult Invasive Cancer NCT06540872Phase 22 sites📍 Essen📍 Münster Universität Münster · Tests: [68Ga]Ga-FAPI-46 [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications NCT07432633Phase 1, Phase 22 sites📍 New York📍 Dallas Blue Earth Diagnostics · Tests: [18F]FPyQCP
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy